Professor John Fraser
MB ChB, PhD, FRCP (Glas), FFARCSI, FRCA, FCICM, FELSO
ORCID # : 0000-0002-7012-2519
Professor & Pre-Eminent Specialist, Intensive Care Medicine, The Prince Charles Hospital
Founder & Director, Critical Care Research Group, University of Queensland & The Prince Charles Hospital
Founder & CMO, De Motu Cordis, Australia
Director, Intensive Care Unit, St Andrew's War Memorial Hospital, Brisbane
Professor Anaesthesiology & Critical Care, School of Medicine, University of Queensland
Professor of Medicine, Bond University
Professor, School of Medicine, Griffith University
Adjunct Professor, Queensland University of Technology
Adjunct Professor, Monash University
Honorary Research Fellow, Australian Red Cross Lifeblood
Affiliate Membership, Translational Research Institute
How John Fraser assembled an international crack team, driving medtech innovation and healthcare research.
Technology developed by De Motu Cordis utilises the pulmonary pathway to deliver life saving medications.
Professor John Fraser has been announced as the official MedTech ambassador for the Brisbane Economic Development Agency.
CCRG hosts world leaders in ICU and critical care research at the inaugural CRIKEY Summit.
Expo 2020 Dubai: World Majlis - At the Speed of Life
DMC progress presented at JP Morgan Week in San Francisco.
JAMA praises COVID-19 Critical Care Consortium for its rapid response during the pandemic.
Did you know 75% of ICU patients will experience cognitive distress while in hospital? Discover world-first project addressing this.
24-year-old Alex received a new heart through “The Living Heart Project”, co-led by Prof Fraser.